OR2T1
Olfactory receptor 2T1
Also known as: OR2T1_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- O43869
- Gene
- OR2T1
- Canonical length
- 369 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for OR2T1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
369 residues, UniProt reviewed canonical sequence.
>O43869|OR2T1
1 MWQEYYFLNV FFPLLKVCCL TINSHVVILL PWECYHLIWK ILPYIGTTVG SMEEYNTSST
61 DFTFMGLFNR KETSGLIFAI ISIIFFTALM ANGVMIFLIQ TDLRLHTPMY FLLSHLSLID
121 MMYISTIVPK MLVNYLLDQR TISFVGCTAQ HFLYLTLVGA EFFLLGLMAY DRYVAICNPL
181 RYPVLMSRRV CWMIIAGSWF GGSLDGFLLT PITMSFPFCN SREINHFFCE APAVLKLACA
241 DTALYETVMY VCCVLMLLIP FSVVLASYAR ILTTVQCMSS VEGRKKAFAT CSSHMTVVSL
301 FYGAAMYTYM LPHSYHKPAQ DKVLSVFYTI LTPMLNPLIY SLRNKDVTGA LKRALGRFKG
361 PQRVSGGVFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OR2T1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 0 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
- appendix: 0 nTPM
- basal ganglia: 0 nTPM
- blood vessel: 0 nTPM
Single-cell type
- brain excitatory neurons: 0.1 nCPM
- brain inhibitory neurons: 0.1 nCPM
- other brain neurons: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
- white matter: 0.1 nTPM
- amygdala: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.92
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.71
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 1% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OR2T1 as an antibody target. Whether an autoantibody or antibody against OR2T1 could matter depends on whether native OR2T1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OR2T1 is annotated at the cell surface, where native OR2T1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OR2T1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...